284620 — Kainos Medicine Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapMomentum Trap

Annual income statement for Kainos Medicine, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0	0	1,662	130	267
Cost of Revenue
Gross Profit	—	0	1,660	91	205
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	44.2	9,386	12,882	14,150	17,056
Operating Profit	-44.2	-9,386	-11,219	-14,020	-16,789
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	90.5	-12,763	-16,224	-15,913	-15,238
Provision for Income Taxes
Net Income After Taxes	80.1	-11,448	-16,225	-15,914	-15,239
Minority Interest
Net Income Before Extraordinary Items
Net Income	80.1	-11,448	-16,212	-15,881	-15,235
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	80.1	-11,448	-16,212	-15,881	-15,235
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	67.2	-511	-695	-724	-561
Dividends per Share